PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Ibuleve
Presentation Product Chemical substance Chapter Items dispensed
Ibuleve Maximum Strength 10% gel
1003020P0BCAFAI
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases 1,161
Ibuleve 5% gel
1003020P0BCAAAC
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases 720
Ibuleve Speed Relief Max Strength 10% gel
1003020P0BCAIAI
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases 22
Ibuleve Speed Relief 5% spray
1003020P0BCAHAD
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases 21
Ibuleve Max Strength Pain Relief 10% Gel
1003020P0BCALAI
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases 13
Ibuleve Speed Relief 5% gel
1003020P0BCAGAC
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases 10
Ibuleve Pain Relief 5% Spray
1003020P0BCAJAD
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases 4
Ibuleve Pain Relief 5% Gel
1003020P0BCAKAC
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases 2
Ibuleve 5% Mousse
1003020P0BCAEAF
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases No data available
Ibuleve 5% spray
1003020P0BCACAD
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases No data available
Ibuleve Sports 5% gel
1003020P0BCABAC
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.